ExPharma Limit has announced the acquisition of Ireland’s Nemysis Limited. Financial Terms have not been made public. Nemysis has a large IP platform of compounds potentially useful for the treatment of symptoms associated with Celiac Disease. Danilo Casadei Massari, the …